DavidPerlmutterMD · 2023-04-17 · David Perlmutter (host), Mark Burhenne

Oral Bacteria And Your Health - with Dr. Mark Burhenne | The Empowering Neurologist EP. 162

40 research-tied claims examined: 1 contradicted 8 overstated 2 context 24 supported 5 unverified

2

Needs context

0:20:05Mark Burhenneneeds contextlow

Gum disease and oral inflammation cross the placental barrier and cause complications such as preterm birth and low birth weight.

"This bug will cross the blood-brain barrier. It crosses the placental barrier as well. That's why women that have gum disease or even inflammation, gingivitis, there are a lot of complications, preterm and low birth weight births, which is pretty common." (said at 0:20:05)

The claim that periodontitis/oral inflammation is associated with adverse birth outcomes like preterm birth (PTB) and low birth weight (LBW) is supported by observational research and mechanistic models. Systematic reviews and meta-analyses of observational studies show that pregnant individuals with periodontal disease have a significantly higher risk of PTB and LBW (e.g., OR = 1.57 for PTB and OR = 2.43 for LBW in prospective/case-control meta-analyses). Preclinical and bioinformatic research also demonstrates that oral pathogens (such as *Porphyromonas gingivalis* and *Fusobacterium nucleatum*) can enter hematogenous circulation and disrupt/cross the placental barrier, inducing inflammatory signaling. However, meta-analyses of randomized controlled trials (RCTs) assessing non-surgical periodontal therapy during pregnancy show that treating periodontal disease does not consistently reduce the risk of PTB or LBW, leading major evaluations (such as those using Bradford Hill criteria) to conclude that a causal relationship remains unproven. Therefore, while oral pathogens can translocate to the placenta and are associated with increased risk of complications, calling them direct causes requires qualification due to the lack of risk reduction upon treatment.

0:29:15Mark Burhenneneeds contextmoderate

Endothelial production of nitric oxide in the human body significantly declines by approximately age 40.

"Typically, by age 40, you know, the endothelial cells and other cells in the body, that that production value drops, but the mouth keeps on going." (said at 0:29:15)

Endothelial nitric oxide (NO) bioavailability and whole-body NO production decline progressively with advancing age, but the timeline differs significantly by sex. Landmark physiological studies of endothelium-dependent flow-mediated dilation show that endothelial function remains relatively stable in healthy men until roughly age 40, after which it begins a steady decline. In healthy women, endothelial function typically remains preserved until the early 50s (around menopause), after which it declines at a steeper rate.

Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.